Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1550 of 2529 entries
View as:

Long-term Safety, Tolerability and Efficacy of Omalizumab in Japanese Children

Phase: N/A Priority: Normal
NCT ID: NCT01328886 Org: User:
Start: 03/31/11 End: 12/31/13 Due: 12/31/14

A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib

Phase: N/A Priority: Normal
NCT ID: NCT03050398 Org: User:
Start: 06/07/17 End: 03/08/19 Due: 03/08/20

Aliskiren in Combination With Losartan Compared to Losartan on the Regression of Left Ventricular Hypertrophy in Overweight Patients With Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00219141 Org: User:
Start: 10/31/05 End: 11/30/07 Due: 11/30/08

A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML).

Phase: N/A Priority: Normal
NCT ID: NCT00946647 Org: User:
Start: 12/02/09 End: 04/29/19 Due: 04/29/20

A Study to Investigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants (≥18 Years of Age) With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP)

Phase: N/A Priority: Normal
NCT ID: NCT05456191 Org: User:
Start: 11/21/22 End: 07/07/31 Due: 07/07/32

Sacubitril/Valsartan Treated Adult Patients With Chronic Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT05613140 Org: User:
Start: 08/02/21 End: 11/05/21 Due: 11/05/22

Study to Allow Patients Previously Participating in a Novartis Sponsored Trial to Continue Receiving Capmatinib Treatment as Single Agent or in Combination With Other Treatments or the Combination Treatment Alone

Phase: N/A Priority: Normal
NCT ID: NCT03040973 Org: User:
Start: 07/04/17 End: 07/30/27 Due: 07/30/28

Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued Treatment

Phase: N/A Priority: Normal
NCT ID: NCT02962414 Org: User:
Start: 06/08/17 End: 08/13/27 Due: 08/13/28

Observational Study of Real World Effectiveness Data and Safety in Patients Receiving Pazopanib With Advanced or Metastatic Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01649778 Org: User:
Start: 07/19/12 End: 07/03/17 Due: 07/03/18

To Evaluate the Safety, Local Tolerability, PK and PD of LDE225 on Sporadic Superficial and Nodular Skin Basal Cell Carcinomas (sBCC)

Phase: N/A Priority: Normal
NCT ID: NCT01033019 Org: User:
Start: 12/31/09 End: 02/28/11 Due: 02/28/12

Real-world Outcomes of Aplastic Anemia Patients Treated With Eltrombopag: A Medical Claims Database Study

Phase: N/A Priority: Normal
NCT ID: NCT06991894 Org: User:
Start: 07/14/21 End: 05/17/24 Due: 05/17/25

Panobinostat or Placebo With Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT01023308 Org: User:
Start: 12/21/09 End: 07/30/15 Due: 07/30/16

A Phase I Dose Escalation Study of BKM120 With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT01473901 Org: User:
Start: 12/30/11 End: 05/17/17 Due: 05/17/18

Efficacy and Safety of Rivastigmine Capsules in Patients With Probable Vascular Dementia

Phase: N/A Priority: Normal
NCT ID: NCT00099216 Org: User:
Start: 08/31/01 End: 11/30/05 Due: 11/30/06

Study of Efficacy and Safety of NIS793 (With and Without Spartalizumab) in Combination With SOC Chemotherapy in First-line Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)

Phase: N/A Priority: Normal
NCT ID: NCT04390763 Org: User:
Start: 10/16/20 End: 05/02/24 Due: 05/02/25

Leqvio rPMS (Regulatory Post-Marketing Surveillance in Korea)

Phase: N/A Priority: Normal
NCT ID: NCT06770543 Org: User:
Start: 07/31/25 End: 01/02/31 Due: 01/02/32

Study of QMF149 (150/80 µg) Compared With MF Twisthaler® (200 µg) in Patients With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT02892344 Org: User:
Start: 01/16/17 End: 11/30/18 Due: 11/30/19

Mayzent (Siponimod) Onboarding of Secondary Progressive Multiple Sclerosis (SPMS) Patients With MSGo

Phase: N/A Priority: Normal
NCT ID: NCT05826028 Org: User:
Start: 07/09/20 End: 04/20/22 Due: 04/20/23

Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder (MDD)

Phase: N/A Priority: Normal
NCT ID: NCT01110902 Org: User:
Start: 05/31/10 End: 06/30/11 Due: 06/30/12

Study of Safety and Efficacy in Patients With Malignant Rhabdoid Tumors (MRT) and Neuroblastoma

Phase: N/A Priority: Normal
NCT ID: NCT01747876 Org: User:
Start: 05/28/13 End: 06/29/17 Due: 06/29/18

ENGYNE Exploring Gilenya in Patients With Neutralizing Antibodies Against Interferon

Phase: N/A Priority: Normal
NCT ID: NCT01621269 Org: User:
Start: 06/30/13 End: 06/30/14 Due: 06/30/15

Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria

Phase: N/A Priority: Normal
NCT ID: NCT06865651 Org: User:
Start: 05/22/25 End: 07/27/27 Due: 07/27/28

A Clinical Study to Assess the Effect of Vildagliptin on Beta Cell Function in Drug Naive Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00260156 Org: User:
Start: 11/30/05 End: 12/31/08 Due: 12/31/09

Study Evaluating TCH346 and Placebo Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis (ALS)

Phase: N/A Priority: Normal
NCT ID: NCT00072709 Org: User:
Start: 09/30/03 End: 12/31/04 Due: 12/31/05

randOmized stUdy Using acceleromeTry to Compare Sacubitril/valsarTan and Enalapril in Patients With Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT02900378 Org: User:
Start: 12/20/16 End: 04/11/18 Due: 04/11/19